Share-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Stock Option Activity

The following table summarizes stock option activity for the years ended December 31, 2023 and 2022:

	Options Outstanding	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)	Aggregated Intrinsic Value
Outstanding at December 31, 2021	174,750	$	217.50	8.06	$	4,596,393
Granted	106,670	37.50		—	—
Exercised	(579)	66.25		—	—
Expired	(8,310)	260.00		—	—
Forfeited	(4,208)	218.75		—	—
Outstanding at December 31, 2022	268,323	146.25		7.80	—
Granted	2,800	4.75		—	—
Exercised	—	—		—	—
Expired	(47,211)	146.70		—	—
Forfeited	(22,679)	105.49		—	—
Outstanding at December 31, 2023	201,233	148.68		6.97	—
Vested as of December 31, 2023	178,266	155.04		6.77	—
Expected to vest as of December 31, 2023	22,967	99.35		8.48	—

Schedule of Assumptions Used to Estimate the Fair Values of the Share Options

For the options with performance and service conditions, the assumptions used to estimate the fair values of the stock options

granted in the year ended December 31, 2023 and 2022 are as follows:

	Year ended
	December 31, 2023		December 31, 2022
Expected term (in years)	5.38		0.5 - 5.55
Expected volatility	128%		96% - 127%
Expected dividend yield	—	%	—	%
Risk free interest rate	3.91%		1.69% - 4.58%

Schedule of Warrants Outstanding and Exercisable

A summary of the warrants is as follows:

	2023	2022
Warrants Outstanding	Number of Warrants Outstanding and Exercisable	Number of Warrants Outstanding and Exercisable	Exercise Price
Acuitas Capital, LLC	—	80,000	$	36.25

Schedule of Unvested Restricted Shares

A summary of the unvested restricted shares is as follows:

	Shares	Weighted-average fair value
Non-vested restricted shares outstanding at December 31, 2021	—	$	—
Granted	70,400	27.50
Forfeited	—	—
Vested	(40,800)	31.25
Non-vested restricted shares outstanding at December 31, 2022	29,600
Granted	222,000	7.87
Forfeited	(17,983)	26.51
Vested	(232,200)	8.88
Non-vested restricted shares outstanding at December 31, 2023	1,417	$	4.75